Natera Inc
(NAS:NTRA)
$
162.39
0.4 (0.25%)
Market Cap: 21.44 Bil
Enterprise Value: 20.99 Bil
PE Ratio: 0
PB Ratio: 22.95
GF Score: 70/100 Natera Inc at Canaccord Genuity Growth Conference Transcript
Aug 10, 2022 / 03:30PM GMT
Release Date Price:
$55.29
(+8.80%)
Kyle Alexander Mikson
Canaccord Genuity Corp., Research Division - Analyst
Good morning, everyone, to the 42nd Annual Canaccord Genuity Global Growth Conference. I'm Kyle Mikson, Life Sciences and Diagnostics at Canaccord, and we are pleased to present Natera here today. Natera is a leader in cell-free DNA-based testing across women's health, oncology and organ health. And with us from the company we have Steve Chapman, CEO; Mike Brophy, CFO. Thanks, guys, for joining us today.
Steven Leonard Chapman
Natera, Inc. - CEO, President & Director
Sure. Thanks for having us.
Michael B. Brophy
Natera, Inc. - CFO
Yes. Thank you.
Questions & Answers
Kyle Alexander Mikson
Canaccord Genuity Corp., Research Division - Analyst
Awesome. So you reported the second quarter results last Thursday, I believe. Great results, I think, almost $200 billion of revenue, solid results across the board. Can you talk about the performance for volume and maybe even ASV across given
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot